Office Address:
1161 21st Ave S, MCN, Room / Suite T-1218, Nashville, TN 37232

Assistant Professor

Hometown
Florissant, Missouri
Previous Institution
University of Michigan
Previous Role/Title
Assistant Professor of Medicine
Specialty
Pulmonary and Critical Care Medicine

Education

MD - University of Missouri-Columbia, 2010
MS, Clinical Research Design and Statistical Analysis - University of Michigan, 2017
BS, Biology - University of Missouri-Columbia, 2006

Postgraduate Training

Internship

Internal Medicine - Rush University Medical Center, 2011

Residency
Internal Medicine - Rush University Medical Center, 2013
Fellowship
Research - University of Michigan, 2017, Pulmonary, and Critical Care Medicine - University of Michigan, 2016
Professional Highlights

Dr. Margaret Salisbury is an Assistant Professor of Medicine on the tenure track. Her primary research interests are 1) clinical and biologic phenotyping in hypersensitivity pneumonitis, 2) interaction of the lung microbiome with the host in hypersensitivity pneumonitis and pulmonary fibrosis, and 3) the role of chest imaging in diagnosis and phenotyping of interstitial lung diseases. A fundamental goal of Dr. Salisbury’s work has been to understand variables associated with subsequent risk of disease progression in patients with fibrosing interstitial lung disease. The research in which Dr. Salisbury has participated has pushed the boundaries of what was previously understood about pulmonary fibrosis in two key areas: identifying predictors of disease progression and refining the approach to diagnostic testing in patients with fibrosing interstitial lung diseases. The overarching goal of her current proposed project is to understand the relationship between the host immune response, the lung microbiome, lung fibrosis, and disease trajectory in patients with HP, as a key step toward improving our ability to provide effective, personalized treatment to patients with this heterogeneous, life-threatening disease. Dr. Salisbury serves as an ad hoc reviewer for several high-impact journals in her field and serves on the editorial board of the journal Annals of the American Thoracic Society. In addition to her awards for academic excellence throughout her education and training, Dr. Salisbury is becoming known as a determined scholar engaged in cutting-edge research through her published work, including several opinion pieces and her regular talks and presentations at national and international conferences.

Research Description
Dr. Salisbury's primary research interests are 1) clinical and biologic phenotyping in hypersensitivity pneumonitis, 2) interaction of the lung microbiome with the host in hypersensitivity pneumonitis and pulmonary fibrosis, and 3) the role of chest imaging in diagnosis and phenotyping of interstitial lung diseases. A fundamental goal of Dr. Salisbury’s work has been to understand variables associated with subsequent risk of disease progression in patients with fibrosing interstitial lung disease. The research in which Dr. Salisbury has participated has pushed the boundaries of what was previously understood about pulmonary fibrosis in two key areas: identifying predictors of disease progression and refining the approach to diagnostic testing in patients with fibrosing interstitial lung diseases. The overarching goal of her current proposed project is to understand the relationship between the host immune response, the lung microbiome, lung fibrosis, and disease trajectory in patients with HP, as a key step toward improving our ability to provide effective, personalized treatment to patients with this heterogeneous, life-threatening disease.